LDI Autologous Antigen Application

Current Status
Not Enrolled
Get Started

This webinar delves into the concept of Autologous Low Dose Immunotherapy (LDI) and its application in treating chronic inflammatory conditions. Dr. Ty Vincent will discuss the rationale behind using self-sampled antigens from patients, including various bodily fluids and tissues, to address autoimmune and inflammatory disorders. He will cover different types of autologous samples, their appropriate uses, collection strategies, and typical starting dosages. This comprehensive overview aims to enhance practitioners’ understanding and facility with autologous LDI, providing practical insights and case examples.

Learning Objectives:

  1. Understand the Concept of Autologous LDI: Learn the principles and rationale behind using self-sampled antigens for treating chronic inflammatory and autoimmune conditions.
  2. Identify Appropriate Autologous Samples: Recognize different types of autologous samples (e.g., blood, stool, urine, oral swabs) and understand their specific applications in various disease conditions.
  3. Master Sample Collection Techniques: Gain knowledge of effective strategies for collecting and preparing autologous samples for LDI treatment.
  4. Determine Starting Dosages: Learn the typical starting dosages for different autologous samples and understand the process of dose titration.
  5. Analyze Case Studies: Review and analyze real-life case studies to understand the practical application and outcomes of autologous LDI in diverse patient scenarios.
  6. Enhance Clinical Decision-Making: Improve your ability to choose the right autologous sample and dosage for specific inflammatory and autoimmune conditions, enhancing patient outcomes.